Adventrx Pharmaceuticals, Inc. Message Board
- Reply to
Only a Dung-4-brains Ignorant Basher Would Quote Adam Fukstein as an Authority.
by butchisrno420 •Apr 13, 2013 5:57 PMAww dr_nisjobe, and all your other hatespewing IDs. You must know that your hateful mindset will just snuff out whatever you have left of the pilot light of your soul. You should concentrate on preserving whatever soul you have left. And get back on your meds, our acting like a fool!
-
U R So FOS Your Post Stinks 4 Miles. Take a Walk Around, "mate". Nobody on this message board is going to pay any attention to a POS like yourself! Go back and jerk off on the ANX board where you belong......LMFAO @ this moron
-
He's got a B.S. degree in Political Science and experience in Real Estate for God's sake. Just a paid Blogster tool, only paid attention to be a FOOL!
- Reply to
All The Positive Factors Are In Place For $22.25 - $22.75 Potential is Unlimited
by thebigmonkey •Apr 11, 2013 3:02 PMMonkey up
- Reply to
All The Positive Factors Are In Place For $22.25 - $22.75 Potential is Unlimited
by thebigmonkey •Apr 11, 2013 3:02 PMLie down on the track, Jack
- Reply to
$36.5 Million in Cash and Cash Equivalents as of Dec 31, 2013
by sorenitylove69h •Apr 6, 2013 7:31 AMTruth up
- Reply to
EUROPEAN COMMISSION DESIGNATES MST-188 AS AN ORPHAN MEDICINAL PRODUCT
by sorenitylove69h •Apr 5, 2013 5:14 PMTruth up
- Reply to
Mast Therapeutics Engages ESC Advisors To Identify Partnering Opportunities For MST-188
by sorenitylove69h •Apr 5, 2013 9:41 PMtRUTH UP
-
Liars are trying to get you to lose money here. read the articles for yourself
-
Affymax (AFFY) submitted its 4th quarter 2012 results and annual report yesterday, and it was not a pretty sight. AFFY wasn't financially prepared to deal with the recent recall of its dialysis drug, OMONTYS.
Its Q412 loss was $68.3 million (or $1.85 per share), a large chunk was from $45.0 million in impairment due to inventory and firm purchase commitments from its recall of OMONTYS. Interestingly, the company didn't set aside any funds in anticipation of the inevitable lawsuits from patients who had a severely bad reaction to OMONTYS. - Reply to
Basic value of $22.75 to $25.00 a share will be set forth on just their land alone
by thebigmonkey •Mar 28, 2013 12:09 PMYepper
- Reply to
The Problem Shorts Have Is They Have To Buy To Cover The $20.00 Will Give Them A nice gift
by soren025 •Apr 4, 2013 3:23 PMUnh-huh
-
#### SPAM SPAM SPAM SPAM SPAM ALERT ####
- Reply to
Do Your Own DD. Bashers Will Lie About Everything.....
by charlotte_observer •Apr 6, 2013 7:45 PMBashers are just posting lies
-
#### SPAM ALERT ####
-
A creepster from another board. A true sociopathetic L-O-S-E-R who knows absolutely nothing about CVM.
-
LOL.......
- Reply to
Pumperz UNHAPPY HOUR In Progress - Free Peanuts and Oldies Music Til Closing Time
by thebigrnonkey •Mar 22, 2013 8:10 AMLOL.........
- Reply to
Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against Affymax
by thebigrnonkey •Mar 22, 2013 8:20 AMDead money here